On Rare Disease Day 2024, we hear from Chris Moore, President, Veeva Europe who explores how companies are overcoming challenges to develop, launch, and educate on new rare disease medicines faster.
Dalip Sethi, Ph.D. and Joy Duemke, at Terumo Blood and Cell Technologies explore how automated apheresis platforms function as a therapeutic and an enabling technology for cell-based therapies.
Bristol Myers Squibb have announced a $400 million investment in their Dublin 15 Cruiserath Campus towards the build and design of a Sterile Drug Product facility.
Niall Balfour, Chief Executive Officer at Tower Cold Chain, explores the sustainability implications associated with both single-use, semi-reusable and fully reusable temperature-controlled shippers.
Takeda and Biological E. Limited, an India-based vaccines and pharmaceutical company, have announced a strategic partnership to accelerate access to QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials.
Ralph Howes, Cold Store Major Accounts Manager, ICS Cool Energy gives us 5 top tips for reducing costs process cooling systems in our latest EPM Online Insight.
Penny Pinnock, Siemens Financial Services, explores how more efficient and accurate technology is contributing to improved healthcare outcomes and helping private hospital groups cope with supporting NHS backlog.
In our latest EPM Online Insight, Andy Clarke, Country Manager (UK), at YSDS explores the complexities and demands of low volume, high value shipments through specialist logistics support.
Bryan Hill (Global / Americas), Gaga Syal (GGM) & Rohit Alimchandani (UK) - Cognizant discuss how life sciences organisations should prepare for the quantum revolution in our latest EPM Online Insights.
FUJIFILM Healthcare Europe has unveiled the ECHELON Synergy, a revolutionary MRI scanner for efficient, high performance imaging with optimal patient comfort.
Jimin Kim, Senior CDO Business Strategist at Samsung Biologics, lays out the challenges of successfully progressing complex biologics from clinic to commercialisation.
